Trade Vaxart, Inc. - VXRT CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.06 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Vaxart Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 0.69 |
Open* | 0.69 |
1-Year Change* | -67.76% |
Day's Range* | 0.66 - 0.69 |
52 wk Range | 0.56-2.94 |
Average Volume (10 days) | 789.67K |
Average Volume (3 months) | 35.61M |
Market Cap | 111.85M |
P/E Ratio | -100.00K |
Shares Outstanding | 151.97M |
Revenue | 2.06M |
EPS | -0.76 |
Dividend (Yield %) | N/A |
Beta | 0.66 |
Next Earnings Date | Nov 6, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 22, 2023 | 0.68 | -0.01 | -1.45% | 0.69 | 0.69 | 0.66 |
Sep 21, 2023 | 0.69 | -0.02 | -2.82% | 0.71 | 0.71 | 0.68 |
Sep 20, 2023 | 0.71 | 0.01 | 1.43% | 0.70 | 0.71 | 0.68 |
Sep 19, 2023 | 0.68 | -0.02 | -2.86% | 0.70 | 0.70 | 0.68 |
Sep 18, 2023 | 0.70 | 0.00 | 0.00% | 0.70 | 0.71 | 0.68 |
Sep 15, 2023 | 0.71 | -0.03 | -4.05% | 0.74 | 0.74 | 0.70 |
Sep 14, 2023 | 0.72 | -0.02 | -2.70% | 0.74 | 0.75 | 0.71 |
Sep 13, 2023 | 0.74 | -0.01 | -1.33% | 0.75 | 0.77 | 0.74 |
Sep 12, 2023 | 0.74 | -0.02 | -2.63% | 0.76 | 0.76 | 0.71 |
Sep 11, 2023 | 0.76 | -0.01 | -1.30% | 0.77 | 0.77 | 0.74 |
Sep 8, 2023 | 0.74 | 0.01 | 1.37% | 0.73 | 0.80 | 0.71 |
Sep 7, 2023 | 0.71 | -0.05 | -6.58% | 0.76 | 0.76 | 0.68 |
Sep 6, 2023 | 0.77 | -0.04 | -4.94% | 0.81 | 0.81 | 0.77 |
Sep 5, 2023 | 0.80 | 0.00 | 0.00% | 0.80 | 0.82 | 0.79 |
Sep 1, 2023 | 0.81 | 0.00 | 0.00% | 0.81 | 0.81 | 0.79 |
Aug 31, 2023 | 0.78 | 0.00 | 0.00% | 0.78 | 0.81 | 0.77 |
Aug 30, 2023 | 0.78 | -0.03 | -3.70% | 0.81 | 0.82 | 0.77 |
Aug 29, 2023 | 0.82 | 0.03 | 3.80% | 0.79 | 0.82 | 0.77 |
Aug 28, 2023 | 0.80 | 0.03 | 3.90% | 0.77 | 0.80 | 0.76 |
Aug 25, 2023 | 0.76 | -0.01 | -1.30% | 0.77 | 0.78 | 0.75 |
Vaxart, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Monday, November 6, 2023 | ||
Time (UTC) 10:59 | Country US
| Event Q3 2023 Vaxart Inc Earnings Release Q3 2023 Vaxart Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 0.107 | 0.892 | 4.046 | 9.862 | 4.159 |
Revenue | 0.107 | 0.892 | 4.046 | 9.862 | 4.159 |
Total Operating Expense | 107.734 | 69.855 | 34.216 | 25.747 | 19.155 |
Selling/General/Admin. Expenses, Total | 29.386 | 21.89 | 15.202 | 6.187 | 6.681 |
Research & Development | 81.054 | 48.749 | 19.863 | 14.54 | 17.275 |
Depreciation / Amortization | |||||
Interest Expense (Income) - Net Operating | |||||
Operating Income | -107.627 | -68.963 | -30.17 | -15.885 | -14.996 |
Interest Income (Expense), Net Non-Operating | 1.241 | 0.08 | 0.062 | -0.198 | -1.032 |
Other, Net | -1.305 | -1.48 | -1.874 | -2.073 | -1.859 |
Net Income Before Taxes | -107.691 | -70.363 | -31.982 | -18.155 | -17.898 |
Net Income After Taxes | -107.758 | -70.47 | -32.22 | -18.645 | -18.007 |
Net Income Before Extra. Items | -107.758 | -70.47 | -32.22 | -18.645 | -18.007 |
Net Income | -107.758 | -70.47 | -32.22 | -18.645 | -18.007 |
Income Available to Common Excl. Extra. Items | -107.758 | -70.47 | -32.22 | -18.645 | -18.346 |
Income Available to Common Incl. Extra. Items | -107.758 | -70.47 | -32.22 | -18.645 | -18.346 |
Diluted Net Income | -107.758 | -70.47 | -32.22 | -18.645 | -18.346 |
Diluted Weighted Average Shares | 127.684 | 121.454 | 88.2958 | 21.5695 | 6.31607 |
Diluted EPS Excluding Extraordinary Items | -0.84394 | -0.58022 | -0.36491 | -0.86441 | -2.90466 |
Dividends per Share - Common Stock Primary Issue | |||||
Diluted Normalized EPS | -0.85772 | -0.58442 | -0.37116 | -0.71317 | -3.39761 |
Gain (Loss) on Sale of Assets | 0 | 0.001 | -0.011 | ||
Total Extraordinary Items | |||||
Total Adjustments to Net Income | 0 | 0 | -0.339 | ||
Unusual Expense (Income) | -2.706 | -0.784 | -0.849 | 5.02 | -4.801 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 1.358 | 0.675 | 0.022 | 0 | 0 |
Revenue | 1.358 | 0.675 | 0.022 | 0 | 0 |
Total Operating Expense | 24.411 | 26.247 | 24.2 | 29.426 | 29.247 |
Selling/General/Admin. Expenses, Total | 5.598 | 6.625 | 6.447 | 6.96 | 9.321 |
Research & Development | 18.813 | 19.622 | 20.459 | 22.466 | 19.926 |
Unusual Expense (Income) | -2.706 | ||||
Operating Income | -23.053 | -25.572 | -24.178 | -29.426 | -29.247 |
Interest Income (Expense), Net Non-Operating | 0.71 | 0.639 | 0.593 | 0.458 | 0.155 |
Other, Net | -0.188 | -0.178 | -0.317 | -0.325 | -0.323 |
Net Income Before Taxes | -22.531 | -25.111 | -23.902 | -29.293 | -29.415 |
Net Income After Taxes | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Net Income Before Extra. Items | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Net Income | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Income Available to Common Excl. Extra. Items | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Income Available to Common Incl. Extra. Items | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Diluted Net Income | -22.55 | -25.14 | -23.918 | -29.309 | -29.43 |
Diluted Weighted Average Shares | 139.594 | 135.213 | 131.612 | 126.89 | 126.428 |
Diluted EPS Excluding Extraordinary Items | -0.16154 | -0.18593 | -0.18173 | -0.23098 | -0.23278 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.16154 | -0.18593 | -0.1951 | -0.23098 | -0.23278 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 99.451 | 169.167 | 128.531 | 17.598 | 14.645 |
Cash and Short Term Investments | 95.717 | 166.487 | 126.87 | 13.526 | 11.506 |
Cash & Equivalents | 30.834 | 70.978 | 60.005 | 13.526 | 11.506 |
Short Term Investments | 49.704 | 22.742 | 0 | ||
Total Receivables, Net | 0.02 | 0.071 | 0.334 | 3.619 | 1.796 |
Accounts Receivable - Trade, Net | 0 | 3.619 | 0 | ||
Prepaid Expenses | 3.714 | 2.609 | 1.327 | 0.453 | 1.343 |
Total Assets | 153.847 | 221.168 | 152.582 | 37.032 | 35.227 |
Property/Plant/Equipment, Total - Net | 41.3 | 19.769 | 8.318 | 2.2 | 1.066 |
Property/Plant/Equipment, Total - Gross | 44.572 | 21.074 | 8.891 | 2.636 | |
Accumulated Depreciation, Total | -3.272 | -1.305 | -0.573 | -1.57 | |
Total Current Liabilities | 17.921 | 10.783 | 11.763 | 9.174 | 7.475 |
Accounts Payable | 5.514 | 3.872 | 2.133 | 0.852 | 0.962 |
Accrued Expenses | 8.444 | 5.339 | 6.219 | 5.406 | 1.407 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 1.667 | |||
Other Current Liabilities, Total | 3.963 | 1.572 | 3.411 | 2.916 | 3.439 |
Total Liabilities | 43.25 | 33.637 | 29.178 | 24.08 | 23.989 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 1.944 |
Long Term Debt | 0 | 1.944 | |||
Other Liabilities, Total | 25.329 | 22.854 | 17.415 | 14.906 | 14.57 |
Total Equity | 110.597 | 187.531 | 123.404 | 12.952 | 11.238 |
Common Stock | 0.013 | 0.013 | 0.011 | 4.825 | 0.714 |
Additional Paid-In Capital | 437.992 | 406.943 | 272.274 | 124.788 | 108.513 |
Retained Earnings (Accumulated Deficit) | -327.109 | -219.351 | -148.881 | -116.661 | -97.989 |
Other Equity, Total | -0.299 | -0.074 | |||
Total Liabilities & Shareholders’ Equity | 153.847 | 221.168 | 152.582 | 37.032 | 35.227 |
Total Common Shares Outstanding | 134.199 | 125.594 | 110.271 | 48.255 | 7.14119 |
Intangibles, Net | 5.02 | 10.624 | 15.361 | 17.093 | 19.413 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Other Long Term Assets, Total | 3.568 | 0.89 | 0.372 | 0.141 | 0.103 |
Cash | 15.179 | 72.767 | 66.865 | ||
Goodwill, Net | 4.508 | 4.508 | |||
Long Term Investments | 0 | 16.21 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 75.83 | 99.451 | 120.38 | 137.81 | 154.18 |
Cash and Short Term Investments | 71.811 | 95.717 | 114.767 | 129.546 | 147.658 |
Cash | 10.255 | 15.179 | 19.895 | 21.833 | 47.31 |
Cash & Equivalents | 38.179 | 30.834 | 30.873 | 69.635 | 76.094 |
Short Term Investments | 23.377 | 49.704 | 63.999 | 38.078 | 24.254 |
Total Receivables, Net | 0.264 | 0.02 | 0 | 0 | 0.081 |
Accounts Receivable - Trade, Net | 0.264 | 0 | 0 | 0.081 | |
Prepaid Expenses | 3.755 | 3.714 | 5.613 | 8.264 | 6.441 |
Total Assets | 129.851 | 153.847 | 175.309 | 181.454 | 200.378 |
Property/Plant/Equipment, Total - Net | 42.216 | 41.3 | 38.887 | 21.769 | 20.499 |
Property/Plant/Equipment, Total - Gross | 46.382 | 44.572 | 41.498 | 23.891 | 22.174 |
Accumulated Depreciation, Total | -4.166 | -3.272 | -2.611 | -2.122 | -1.675 |
Intangibles, Net | 4.837 | 5.02 | 9.611 | 9.949 | 10.286 |
Long Term Investments | 0 | 0 | 1.94 | 9.349 | |
Other Long Term Assets, Total | 2.46 | 3.568 | 1.923 | 5.478 | 1.556 |
Total Current Liabilities | 15.683 | 17.921 | 21.74 | 15.926 | 11.035 |
Accounts Payable | 3.882 | 5.514 | 7.916 | 5.007 | 4.017 |
Accrued Expenses | 7.23 | 8.444 | 9.876 | 8.13 | 5.009 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 4.571 | 3.963 | 3.948 | 2.789 | 2.009 |
Total Liabilities | 40.098 | 43.25 | 53.002 | 38.36 | 34.013 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 24.415 | 25.329 | 31.262 | 22.434 | 22.978 |
Total Equity | 89.753 | 110.597 | 122.307 | 143.094 | 166.365 |
Common Stock | 0.014 | 0.013 | 0.013 | 0.013 | 0.013 |
Additional Paid-In Capital | 442.068 | 437.992 | 426.003 | 417.372 | 411.113 |
Retained Earnings (Accumulated Deficit) | -352.249 | -327.109 | -303.191 | -273.882 | -244.452 |
Other Equity, Total | -0.07 | -0.299 | -0.518 | -0.409 | -0.309 |
Total Liabilities & Shareholders’ Equity | 129.851 | 153.847 | 175.309 | 181.454 | 200.378 |
Total Common Shares Outstanding | 135.597 | 134.199 | 128.331 | 126.446 | 125.841 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Goodwill, Net | 4.508 | 4.508 | 4.508 | 4.508 | 4.508 |
Treasury Stock - Common | -0.01 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -107.758 | -70.47 | -32.22 | -18.645 | -18.007 |
Cash From Operating Activities | -94.779 | -59.832 | -23.75 | -13.09 | -14.548 |
Cash From Operating Activities | 5.805 | 4.208 | 2.71 | 3.596 | 3.203 |
Non-Cash Items | 13.872 | 8.55 | 2.955 | 0.677 | -2.194 |
Changes in Working Capital | -6.698 | -2.12 | 2.805 | 1.282 | 2.45 |
Cash From Investing Activities | -20.415 | -49.097 | -1.22 | -0.85 | 26.212 |
Capital Expenditures | -9.601 | -5.157 | -1.223 | -0.85 | -0.707 |
Other Investing Cash Flow Items, Total | -10.814 | -43.94 | 0.003 | 0 | 26.919 |
Cash From Financing Activities | 17.462 | 125.804 | 138.314 | 15.96 | -1.729 |
Financing Cash Flow Items | 0 | 0.652 | |||
Issuance (Retirement) of Debt, Net | 0 | 0 | -3.799 | -1.742 | |
Net Change in Cash | -97.732 | 16.875 | 113.344 | 2.02 | 9.935 |
Cash Interest Paid | 0 | 0 | 0 | 0.227 | 0.356 |
Issuance (Retirement) of Stock, Net | 17.462 | 125.804 | 137.662 | 19.759 | 0.013 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -25.14 | -107.758 | -83.84 | -54.531 | -25.101 |
Cash From Operating Activities | -24.46 | -94.779 | -65.627 | -51.012 | -25.113 |
Cash From Operating Activities | 2.062 | 5.805 | 3.915 | 2.352 | 1.131 |
Non-Cash Items | 2.264 | 13.872 | 11.017 | 7.132 | 3.435 |
Changes in Working Capital | -3.646 | -6.698 | 3.281 | -5.965 | -4.578 |
Cash From Investing Activities | 25.461 | -20.415 | -36.216 | -5.143 | 3.732 |
Capital Expenditures | -1.239 | -9.601 | -10.738 | -3.672 | -1.346 |
Other Investing Cash Flow Items, Total | 26.7 | -10.814 | -25.478 | -1.471 | 5.078 |
Cash From Financing Activities | 1.42 | 17.462 | 8.866 | 3.878 | 1.04 |
Issuance (Retirement) of Stock, Net | 1.43 | 17.462 | 8.866 | 3.878 | 1.04 |
Net Change in Cash | 2.421 | -97.732 | -92.977 | -52.277 | -20.341 |
Financing Cash Flow Items | -0.01 | ||||
Cash Interest Paid | 0 | ||||
Issuance (Retirement) of Debt, Net |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Cantor Fitzgerald, L.P | Investment Advisor | 4.663 | 7086341 | 7086341 | 2023-06-30 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.5367 | 6894401 | -169485 | 2023-06-30 | LOW |
Millennium Management LLC | Hedge Fund | 1.4106 | 2143638 | 2067766 | 2023-06-30 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2459 | 1893422 | -5968529 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0324 | 1568909 | -1093564 | 2023-06-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.5212 | 792005 | 735548 | 2023-06-30 | HIGH |
Citadel Advisors LLC | Hedge Fund | 0.4933 | 749684 | 270134 | 2023-06-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.4867 | 739643 | -253580 | 2023-06-30 | LOW |
Finney Michael J | Individual Investor | 0.4414 | 670840 | 7375 | 2023-06-26 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3466 | 526745 | -2126874 | 2023-06-30 | LOW |
Rokos Capital Management LLP | Hedge Fund | 0.329 | 500000 | 500000 | 2023-06-30 | HIGH |
Two Sigma Investments, LP | Hedge Fund | 0.2985 | 453670 | -1839853 | 2023-06-30 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.286 | 434690 | -21186 | 2023-06-30 | MED |
Susquehanna International Group, LLP | Investment Advisor | 0.2608 | 396311 | 324032 | 2023-06-30 | HIGH |
Cubist Systematic Strategies, LLC | Hedge Fund | 0.2314 | 351661 | 341109 | 2023-06-30 | HIGH |
Goldman Sachs & Company, Inc. | Research Firm | 0.2259 | 343288 | 254141 | 2023-06-30 | HIGH |
XTX Markets LLC | Venture Capital | 0.2197 | 333829 | 333829 | 2023-06-30 | HIGH |
D. E. Shaw & Co., L.P. | Hedge Fund | 0.1708 | 259516 | -721867 | 2023-06-30 | HIGH |
IHT Wealth Management, LLC | Investment Advisor | 0.1692 | 257128 | -4095 | 2023-06-30 | MED |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.156 | 237116 | -773984 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Vaxart Company profile
Vaxart Inc. is a clinical-stage biotechnology company headquartered in San Francisco, California. It works on the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. It also has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company’s proprietary oral vaccine platform for the Janssen universal influenza vaccine program.
Vaxart is traded on the Nasdaq under the ticker VXRT. In its finance for Q4 2021, the company reported revenue totalling $0.89m, a 77.9% decrease from the $4.04m result in 2020.
Industry: | Bio Therapeutic Drugs |
170 Harbor Way, Suite 300
94080
Income Statement
- Annual
- Quarterly
News

EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023
Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally
The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.
13:46, 15 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com